Independent Director Retires from Bafna Pharmaceuticals; Board Committees Reconstituted
Bafna Pharmaceuticals Ltd has announced the retirement of an independent director, Mr. Navin Kumar, resulting in changes to several board committees. The change is effective as of June 22, 2026.Mr. Navin Kumar, whose DIN is 08778662, will retire from his role as an Independent Director upon the completion of his first term. Consequently, he will also cease to serve as the Chairman of both the Audit Committee and the Nomination & Remuneration Committee.
Following this change in the composition of the Board of Directors, Bafna Pharmaceuticals Ltd has reconstituted several key committees with effect from June 23, 2026. The members and chairpersons for the affected committees have been updated to ensure continued oversight across corporate governance areas.
The details regarding the retirement of Mr. Navin Kumar are as follows:
| Particulars | Description |
|---|---|
| Name of Director | Mr. Navin Kumar |
| Reason for change | Retirement upon completion of first term |
| Date of Cessation | Close of Business Hours on June 22, 2026 |
The composition of the Audit Committee and the Nomination and Remuneration Committee has been revised to include new members:
Audit Committee Composition
| Name of the Director | Designation & Category |
|---|---|
| Mr. Palamadai Krishnan Sundaresan | Chairman (Non-Executive, Independent) |
| Mrs. Ravichandran Chitra | Member (Non-Executive, Independent) |
| Mr. Upendar Mekala Reddy | Member (Non-Executive, Non-Independent) |
Nomination and Remuneration Committee Composition
| Name of the Director | Designation & Category |
|---|---|
| Mr. Palamadai Krishnan Sundaresan | Chairman (Non-Executive, Independent) |
| Mrs. Ravichandran Chitra | Member (Non-Executive, Independent) |
| Mrs. Akila Chintalapati Raju | Member (Non-Executive, Non-Independent) |
Bafna Pharmaceuticals Ltd stated that notwithstanding the retirement of Mr. Navin Kumar, the composition of its Board and its Committees remains compliant with applicable laws.
BAFNAPH Stock Price Movement
Today, Bafna Pharmaceuticals Limited shares gained 4.99% as they closed at ₹168.19, reflecting robust buying interest in the stock. Trading activity saw 27,611 shares move through the session, with the stock trading within an intraday range spanning from ₹160.51 to ₹168.19.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.